These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33745434)

  • 1. Mannosylated Solid Lipid Nanocarriers of Chrysin to Target Gastric Cancer: Optimization and Cell Line Study.
    Pandey SS; Shaikh FI; Gupta AR; Vaidya RJ
    Curr Drug Deliv; 2021; 18(10):1574-1584. PubMed ID: 33745434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of Chrysin-Phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity.
    Komath S; Garg A; Wahajuddin M
    J Microencapsul; 2018 Sep; 35(6):600-617. PubMed ID: 30557060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 7. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation.
    Unnisa A; Chettupalli AK; Al Hagbani T; Khalid M; Jandrajupalli SB; Chandolu S; Hussain T
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
    Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
    Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
    Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway.
    Wang J; Zhu R; Sun X; Zhu Y; Liu H; Wang SL
    Int J Nanomedicine; 2014; 9():3987-98. PubMed ID: 25187702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
    Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
    Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
    Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting.
    Patel P; Raval M; Airao V; Bhatt V; Shah P
    J Microencapsul; 2022 Jan; 39(1):1-24. PubMed ID: 34825627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
    Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation.
    Zewail MB; F Asaad G; Swellam SM; Abd-Allah SM; K Hosny S; Sallah SK; E Eissa J; S Mohamed S; El-Dakroury WA
    Int J Pharm; 2022 Aug; 624():122006. PubMed ID: 35820515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.